Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Microalbuminuria in subjects with hypertension attending specialist blood pressure clinics

Abstract

Albuminuria is associated with increased risk of cardiovascular disease and target organ damage in patients with diabetes mellitus. In nondiabetic hypertensive patients, the threshold at which microalbuminuria (MAU) increases risk is unclear and there is evidence that cardiovascular risk may be increased in individuals with MAU levels lower than the usual recommended screening thresholds. We compared two definitions of MAU (on the basis of three early morning urine samples) in a cohort of hypertensive patients attending two specialist clinics in Scotland: conventional (MAU(C)) albumin-to-creatinine ratio (ACR) >2.5–25 mg mmol−1 in males or >3.5–25 mg mmol−1 in females; and low-grade (MAU(L)) ACR 1.2–2.5 in males or 1.7–3.5 mg mmol−1 in females. Of the 1059 subjects screened, 786 (74%) were nondiabetic, with estimated glomerular filtration rate 30 ml min−1 per 1.73 m2 and without gross proteinuria (low-risk subset). The average age was 58±15 years, body mass index 30±6 kg m−2 and 46% were males. The prevalence of MAU(C) was 11% and 9.5% in the overall and low-risk subset, respectively, whereas MAU(L) prevalence was 11.1% and 10% respectively. The prevalence of cardiovascular disease was higher (24%) with albuminuria (both MAU(C) and MAU(L)) compared with 14% among those without albuminuria. The use of MAU(L) doubled the number of hypertensive subjects with increased cardiovascular risk who can be targeted for more rigorous risk reduction strategies. Consideration should be given to reducing the current threshold for MAU.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Pascual JM, Rodilla E, Costa JA, Garcia-Escrich M, Gonzalez C, Redon J . Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension. Hypertension 2014; 64: 1228–1234.

    Article  CAS  Google Scholar 

  2. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR . Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225–232.

    Article  Google Scholar 

  3. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421–426.

    Article  CAS  Google Scholar 

  4. National Collaborating Centre for Chronic Conditions Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Royal College of Physicians: London, 2008 cited 12 December 2011; Available from: http://www.ncbi.nlm.nih.gov/books/NBK53885/pdf/TOC.pdf.

  5. Pedrinelli R, Dell'Omo G, Penno G, Di Bello V, Giorgi D, Pellegrini G et al. Microalbuminuria, a parameter independent of metabolic influences in hypertensive men. J Hypertens 2003; 21: 1163–1169.

    Article  CAS  Google Scholar 

  6. Pedrinelli R, Dell’Omo G, Di Bello V, Pellegrini G, Pucci L, Del Prato S et al. Low-grade inflammation and microalbuminuria in hypertension. Arterioscler Thromb Vasc Biol 2004; 24: 2414–2419.

    Article  CAS  Google Scholar 

  7. Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, QuartiTrevano F et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens 2009; 27: 2458–2464.

    Article  CAS  Google Scholar 

  8. Dell'omo G, Giorgi D, Di Bello V, Mariani M, Pedrinelli R . Blood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive men. J Intern Med 2003; 254: 76–84.

    Article  CAS  Google Scholar 

  9. Wachtell K, Olsen M, Dahlöf B, Devereux R, Kjeldsen S, Nieminen M et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. J Hypertens 2002; 20: 405–412.

    Article  CAS  Google Scholar 

  10. Hillege H, Fidler V, Diercks G, van Gilst W, de Zeeuw D, van Veldhuisen D et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777–1782.

    Article  CAS  Google Scholar 

  11. Chronic Kidney Disease Prognosis Consortium Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073–2081.

    Article  Google Scholar 

  12. Zamora C, Cubeddu L . Microalbuminuria: do we need a new threshold? J Hum Hypertens 2008; 23: 146–149.

    Article  Google Scholar 

  13. de Jong PE, Curhan GC . Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 2006; 17: 2120–2126.

    Article  Google Scholar 

  14. Levey A, Coresh J, Balk E, Kausz A, Levin A, Steffes M et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–147.

    Article  Google Scholar 

  15. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247–254.

    Article  CAS  Google Scholar 

  16. Böhm M, Thoenes M, Danchin N, Bramlage P, La Puerta P, Volpe M . Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens 2007; 25: 2317–2324.

    Article  Google Scholar 

  17. Lin C, Chen H, Pan C, Hsieh W, Ho H, Wu C . The characteristics of new semi-quantitative method for diagnosing proteinuria by using random urine samples. J Clin Lab Anal 2011; 25: 14–19.

    Article  CAS  Google Scholar 

  18. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Hypertension 1997; 30: 1135–1143.

    Article  CAS  Google Scholar 

  19. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355: 253–259.

    Article  Google Scholar 

  20. Leoncini G, Viazzi F, Rosei E, Ambrosioni E, Costa F, Leonetti G et al. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010; 28: 156–162.

    Article  CAS  Google Scholar 

  21. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32–35.

    Article  CAS  Google Scholar 

  22. Ohmaru N, Nakatsu T, Izumi R, Mashima K, Toki M, Kobayashi A et al. Distribution pattern of urine albumin creatinine ratio and the prevalence of high-normal levels in untreated asymptomatic non-diabetic hypertensive patients. Intern Med 2011; 50: 1621–1629.

    Article  CAS  Google Scholar 

  23. Coresh J, Astor B, Greene T, Eknoyan G, Levey A . Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey. Am J Kidney Dis 2003; 41: 1–12.

    Article  Google Scholar 

  24. Wachtell K, Ibsen H, Olsen M, Borch-Johnsen K, Lindholm L, Mogensen C et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study. Ann Intern Med 2003; 139: 901–906.

    Article  Google Scholar 

  25. Yuyun M, Khaw K, Luben R, Welch A, Bingham S, Day N et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British Population. Am J Epidemiol 2004; 159: 284–293.

    Article  Google Scholar 

  26. Ärnlöv J, Evans J, Meigs J, Wang T, Fox C, Levy D et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals. The Framingham Heart Study. Circulation 2005; 112: 969–975.

    Article  Google Scholar 

  27. Cerasola G, Mule G, Nardi E, Cusimano P, Palermo A, Arsena R et al. Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study. J Hum Hypertens 2010; 24: 44–50.

    Article  CAS  Google Scholar 

  28. Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, Tsiachris D, Stefanadi E et al. ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study. Am J Kidney Dis 2010; 55: 1050–1059.

    Article  CAS  Google Scholar 

  29. Graziani M, Gambaro G, Mantovani L, Sorio A, Yabarek T, Abaterusso C et al. Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. Nephrol Dial Transplant 2009; 24: 1490–1494.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Padmanabhan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Journal of Human Hypertension website .

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alharf, A., Cleland, S., Webster, J. et al. Microalbuminuria in subjects with hypertension attending specialist blood pressure clinics. J Hum Hypertens 30, 527–533 (2016). https://doi.org/10.1038/jhh.2015.116

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2015.116

Search

Quick links